| Katherine Tingting Chang, MD | |
|
9855 Hospital Dr Ste 275, Maple Grove, MN 55369-4778 | |
| (952) 993-3282 | |
| Not Available |
| Full Name | Katherine Tingting Chang |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 9855 Hospital Dr Ste 275, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366860108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD187417 (Oregon) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 71097 (Minnesota) | Primary |
| Entity Name | Park Nicollet Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
The Judy and Bernard Briskin Family Foundation has announced a gift to launch the new Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope, the third named center within City of Hope's new Hematologic Malignancies and Stem Cell Transplantation Institute. The generous gift will enable the institution to further its already considerable accomplishments in the field of myeloma treatment and research.
A new study by UT Health San Antonio researchers found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer.
An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred without any meeting, and when such meetings occurred, pharmaceutical companies did not comply with one-quarter of the recommendations made by the FDA regarding study design or primary outcome, according to a study in the November 26 issue of JAMA.
For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large randomized clinical trial published in 2003 demonstrated a survival benefit for neoadjuvant, or pre-surgical, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) using a standard dose and schedule.
A new study from a Massachusetts General Hospital research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Tingting Chang, MD 8170 33rd Ave S # Ms 21110q, Bloomington, MN 55425-4516 Ph: () - | Katherine Tingting Chang, MD 9855 Hospital Dr Ste 275, Maple Grove, MN 55369-4778 Ph: (952) 993-3282 |
News Archive
The Judy and Bernard Briskin Family Foundation has announced a gift to launch the new Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope, the third named center within City of Hope's new Hematologic Malignancies and Stem Cell Transplantation Institute. The generous gift will enable the institution to further its already considerable accomplishments in the field of myeloma treatment and research.
A new study by UT Health San Antonio researchers found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer.
An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred without any meeting, and when such meetings occurred, pharmaceutical companies did not comply with one-quarter of the recommendations made by the FDA regarding study design or primary outcome, according to a study in the November 26 issue of JAMA.
For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large randomized clinical trial published in 2003 demonstrated a survival benefit for neoadjuvant, or pre-surgical, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) using a standard dose and schedule.
A new study from a Massachusetts General Hospital research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer
› Verified 9 days ago
Kathryn G Flory, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Christine Suzanne Goudge Walker, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 15800 95th Ave N, Park Nicollet - Dept Of Ob/gyn, Maple Grove, MN 55369 Phone: 952-993-3282 | |
Katie Corcoran, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Dr. Sarah A Wernimont, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 14500 99th Ave N, Maple Grove, MN 55369 Phone: 763-898-1000 | |
Dr. Brigette Beth Ritter Miest, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15800 95th Ave N, Park Nicollet Maple Grove, Maple Grove, MN 55369 Phone: 952-993-3282 Fax: 952-993-1425 | |
Kristin M Lyerly, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9855 Hospital Dr, Maple Grove, MN 55369 Phone: 952-993-3282 | |
Leslee J Jaeger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9875 Hospital Dr, Maple Grove, MN 55369 Phone: 763-581-1100 |